Here you will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists and analysts/investors.
Subscribe to our RSS feed
|Media Enquiries - CSL Limited|
Head of Communications, Asia Pacific
Phone: +613 9389 3473
Mobile: +61 412 635 483
FY2017 profit upgrade
CSL Limited (ASX:CSL; USOTC:CSLLY) today upgraded its net profit after tax (NPAT) expectation for FY2017. Following strong sales performance, particularly by immunoglobulins and specialty products in the most recent financial quarter, CSL expects to report NPAT of approximately US$800 million for the six months ended 31 December 2016.
Prior Archived Newsroom